𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of 5-Aza-2′-deoxycytidine in advanced ovarian carcinoma

✍ Scribed by Sessa, Cristiana; Ten Bokkel Huinink, Wim; Stoter, Gerrit; Renard, Josette; Cavalli, Franco

Book ID
123024484
Publisher
Elsevier Science
Year
1990
Weight
202 KB
Volume
26
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study on 5-aza-2′-deoxycytidine
Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia
✍ Georges E. Rivard; Richard L. Momparler; Jocelyn Demers; Paul Benoit; Richard Ra 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Ahstract--A Phase I study with 5-aza-2'-deoxycytidine (5-AZA-CdR) was performed on children with acute leukemia who were resistant to conventional chemotherapy. The objective of this study was to find the dose-schedule of 5-AZA-CdR that produced a potent antileukemic effect and to evaluate its toxic

Phase II trial of vinblastine in advance
Phase II trial of vinblastine in advanced ovarian carcinoma
✍ Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 231 KB

A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro